Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

A consensus statement on dual purpose pathogen surveillance systems: the Always On approach

Journal article

van der Westhuizen H-M. et al, (2024), PLOS Global Public Health

Predicting future hospital antimicrobial resistance prevalence using machine learning

Journal article

VIHTA K-D. et al, (2024), Communications Medicine

Stop antibiotics when you feel better? Opportunities, challenges and research directions

Journal article

BOREK A. et al, (2024), JAC-Antimicrobial Resistance

Why Was the Azithromycin "for Life" Trial Necessary?

Other

Maitland K. and Walker AS., (2024), N Engl J Med, 391, 760 - 762

Determining sample size in a personalised randomised controlled (PRACTical) trial

Journal article

Turner RM. et al, (2024), Statistics in Medicine

Biomarkers of mortality in adults and adolescents with advanced HIV in sub-Saharan Africa

Journal article

Riitho V. et al, (2024), Nature Communications

Overcoming challenges in the economic evaluation of interventions to optimise antibiotic use

Journal article

ROOPE L. et al, (2024), Communications Medicine

Load More